The intestinal microbiome in type 1 diabetes

Clinical and Experimental Immunology

Volumn 177, Issue 1, 2014, Pages 30-37

  Dunne, J L ^a   Triplett, E W ^b   Gevers, D ^c   Xavier, R ^c   Insel, R ^a   Danska, J ^d,e,f   Atkinson, M A ^b  

^a JDRF   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autoimmunity; Immunology; Insulin; Intestinal physiology; Microbiome

Indexed keywords

ARTICLE; DISEASE COURSE; HOST; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MICROBIOME; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AUTOIMMUNITY; IMMUNOLOGY; INSULIN; INTESTINAL PHYSIOLOGY; MICROBIOME;

ANIMALS; BIOLOGICAL MARKERS; BIOLOGICAL THERAPY; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; INTESTINES; MICROBIOTA;

EID: 84904241519     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12321     Document Type: Article

References (57)

1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358:221-229.
2. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2013; 383:69-82.
3. Bodansky HJ, Staines A, Stephenson C, Haigh D, Cartwright R. Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. BMJ 1992; 304:1020-1022.
4. Gillespie KM, Bain SC, Barnett AH etal. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 2004; 364:1699-1700.
5. Klemetti P, Savilahti E, Ilonen J, Akerblom HK, Vaarala O. T-cell reactivity to wheat gluten in patients with insulin-dependent diabetes mellitus. Scand J Immunol 1998; 47:48-53.
6. Norris JM, Barriga K, Klingensmith G etal. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003; 290:1713-1720.
7. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003; 290:1721-1728.
8. Wen L, Ley RE, Volchkov PY etal. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455:1109-1113.
9. Koenig JE, Spor A, Scalfone N etal. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 2011; 108 (Suppl. 1):4578-4585.
10. Arpaia N, Campbell C, Fan X etal. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504:451-455.
11. Brown CT, Davis-Richardson AG, Giongo A etal. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLOS ONE 2011; 6:e25792.
12. Markle JG, Frank DN, Mortin-Toth S etal. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013; 339:1084-1088.
13. de Goffau MC, Luopajärvi K, Knip M etal. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 2013; 62:1238-1244.
14. Giongo A, Gano KA, Crabb DB etal. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011; 5:82-91.
15. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, Group ES. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373:2027-2033.
16. Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Akerblom HK. Environmental triggers and determinants of type 1 diabetes. Diabetes 2005; 54 (Suppl. 2):S125-136.
17. Vaarala O, Atkinson MA, Neu J. The 'perfect storm' for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008; 57:2555-2562.
18. Olszak T, An D, Zeissig S etal. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336:489-493.
19. Hansen CH, Nielsen DS, Kverka M etal. Patterns of early gut colonization shape future immune responses of the host. PLOS ONE 2012; 7:e34043.
20. Bosi E, Molteni L, Radaelli MG etal. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006; 49:2824-2827.
21. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008; 371:1777-1782.
22. Dominguez-Bello MG, Costello EK, Contreras M etal. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010; 107:11971-11975.
23. Patelarou E, Girvalaki C, Brokalaki H, Patelarou A, Androulaki Z, Vardavas C. Current evidence on the associations of breastfeeding, infant formula, and cow's milk introduction with type 1 diabetes mellitus: a systematic review. Nutr Rev 2012; 70:509-519.
24. Lempainen J, Tauriainen S, Vaarala O etal. Interaction of enterovirus infection and cow's milk-based formula nutrition in type 1 diabetes-associated autoimmunity. Diabetes Metab Res Rev 2012; 28:177-185.
25. Oikarinen S, Tauriainen S, Hober D etal. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes. Diabetes 2013; 63:655-662.
26. Brugman S, Klatter FA, Visser JT etal. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006; 49:2105-2108.
27. Schwartz RF, Neu J, Schatz D, Atkinson MA, Wasserfall C. Comment on: Brugman S etal. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108. Diabetologia 2007; 50:220-221.
28. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911-920.
29. King C, Sarvetnick N. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLOS ONE 2011; 6:e17049.
30. Lau K, Benitez P, Ardissone A etal. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol 2011; 186:3538-3546.
31. Murri M, Leiva I, Gomez-Zumaquero JM etal. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med 2013; 11:46.
32. Hagopian WA, Erlich H, Lernmark A etal. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421000 infants. Pediatr Diabetes 2011; 12:733-743.
33. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207-214.
34. Dave M, Higgins PD, Middha S, Rioux KP. The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 2012; 160:246-257.
35. Lönnrot M, Korpela K, Knip M etal. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes 2000; 49:1314-1318.
36. Peet A, Hämäläinen AM, Kool P etal. Early postnatal growth in children with HLA-conferred susceptibility to type 1 diabetes. Diabetes Metab Res Rev 2013; 30:60-68.
37. Peet A, Kool P, Ilonen J, Knip M, Tillmann V, Group DS. Birth weight in newborn infants with different diabetes-associated HLA genotypes in three neighbouring countries: Finland, Estonia and Russian Karelia. Diabetes Metab Res Rev 2012; 28:455-461.
38. Ziegler AG, Meier-Stiegen F, Winkler C, Bonifacio E, Group TS. Prospective evaluation of risk factors for the development of islet autoimmunity and type 1 diabetes during puberty - TEENDIAB: study design. Pediatr Diabetes 2012; 13:419-424.
39. Penno MA, Couper JJ, Craig ME etal. Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatr 2013; 13:124.
40. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. Pediatr Diabetes 2007; 8:286-298.
41. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLOS Biol 2007; 5:e177.
42. Yatsunenko T, Rey FE, Manary MJ etal. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-227.
43. van Nood E, Vrieze A, Nieuwdorp M etal. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:407-415.
44. Angelberger S, Reinisch W, Makristathis A etal. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013; 108:1620-1630.
45. McDonald JA, Schroeter K, Fuentes S etal. Evaluation of microbial community reproducibility, stability and composition in a human distal gut chemostat model. J Microbiol Methods 2013; 95:167-174.
46. Allen-Vercoe E, Reid G, Viner N etal. A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol 2012; 26:457-462.
47. Petrof EO, Claud EC, Gloor GB, Allen-Vercoe E. Microbial ecosystems therapeutics: a new paradigm in medicine? Benef Microbes 2013; 4:53-65.
48. Kump PK, Gröchenig HP, Lackner S etal. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 2013; 19:2155-2165.
49. van Nood E, Speelman P, Nieuwdorp M, Keller J. Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol 2014; 30:34-39.
50. Hummel S, Pflüger M, Hummel M, Bonifacio E, Ziegler AG. Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care 2011; 34:1301-1305.
51. Marietta EV, Gomez AM, Yeoman C etal. Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLOS ONE 2013; 8:e78687.
52. Cooke A, Tonks P, Jones FM etal. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 1999; 21:169-176.
53. Sandborn WJ, Elliott DE, Weinstock J etal. Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease. Aliment Pharmacol Ther 2013; 38:255-263.
54. Ishikawa H, Ochi H, Chen ML, Frenkel D, Maron R, Weiner HL. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody. Diabetes 2007; 56:2103-2109.
55. Herold KC, Gitelman SE, Ehlers MR etal. Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes 2013; 62:3766-3774.
56. Barrett JC, Clayton DG, Concannon P etal. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41:703-707.
57. Minot S, Grunberg S, Wu GD, Lewis JD, Bushman FD. Hypervariable loci in the human gut virome. Proc Natl Acad Sci USA 2012; 109:3962-3966.